Loading...

Alphamab Oncology

9966.HKHKSE
Healthcare
Biotechnology
HK$8.03
HK$0.00(0.00%)

Alphamab Oncology (9966.HK) Stock Chart & Performance Analysis

Explore Alphamab Oncology’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
2.60%
5-Day Change
-19.21%
1-Month Change
19.80%
3-Month Change
81.35%
6-Month Change
41.87%
Year-to-Date (YTD) Change
72.89%
1-Year Change
24.58%
3-Year Change
-24.46%
5-Year Change
-62.23%
All-Time (Max) Change
-56.07%

Analyzing Alphamab Oncology (9966.HK) Trends Across Multiple Time Frames

Alphamab Oncology Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Alphamab Oncology stock shows 2.60% 1-day change, indicating immediate volatility, while its 5-day change of -19.21% suggests a broader trend. Over a 1-month period, a 19.80% rise could signal a pushback, whereas a 3-month rise of 81.35% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 41.87% and a YTD rise of 72.89% might concern investors, but a 1-year gain of 24.58% and a 3-year drop of -24.46% could indicate resilience. The 5-year surge of -62.23% highlights weak historical growth, while the all-time return of -56.07% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;